GSK3B and lung carcinoma: Previous research also proposed that FAM83A can inhibit GSK3β activity and increase the level of active unphosphorylated β-catenin and active β-catenin can transports into the nucleus thus activating the Wnt signaling pathway in lung cancer [23].